Publications by authors named "Xian Rong Qi"

Article Synopsis
  • This study explores the use of a Transformer-based network, specifically the Swin Transformer, to predict isocitrate dehydrogenase (IDH) mutation status in glioma patients using MRIs, without relying on detailed tumor segmentation.
  • A total of 493 glioma patients were analyzed, and various input strategies were tested, including full tumor slices and bounding boxes of varying sizes, revealing that the Swin Transformer achieved higher performance (AUC of 0.965 on internal tests) compared to conventional ResNet models.
  • Incorporating clinical features like age and location alongside imaging data in a hybrid model yielded further improved prediction accuracy (AUC of 0.878), demonstrating the potential of Transformer-based
View Article and Find Full Text PDF

Amorphous solid dispersions (ASD) are one of most commonly used supersaturating drug delivery systems (SDDS) to formulate insoluble active pharmaceutical ingredients. However, the development of polymer-guided stabilization of ASD systems faces many obstacles. To overcome these shortcomings, co-amorphous supersaturable formulations have emerged as an alternative formulation strategy for poorly soluble compounds.

View Article and Find Full Text PDF

This study aimed to explore the link between block copolymers' interfacial properties and nanoscale carrier formation and found out the influence of length ratio on these characters to optimize drug delivery system. A library of diblock copolymers of PEG-PCL and triblock copolymers with additional PEI (PEG-PCL-PEI) were synthesized. Subsequently, a systematic isothermal investigation was performed to explore molecular arrangements of copolymers at air/water interface.

View Article and Find Full Text PDF

Many strategies have been employed to improve oral drug delivery. One such approach involves the use of supersaturable delivery systems such as amorphous self-micellizing solid dispersions (SmSDs). SmSDs have attracted more attention recently, but little is known regarding the impact of production methods on profiles and internal mechanisms of final SmSDs in spite of its importance.

View Article and Find Full Text PDF

The collective impact of cellulosic polymers on the dissolution, solubility, and crystallization inhibition of amorphous active pharmaceutical ingredients (APIs) is still far from being adequately understood. The goal of this research was to explore the influence of cellulosic polymers and incubation conditions on enhancement of solubility and dissolution of amorphous felodipine, while inhibiting crystallization of the drug from a supersaturated state. Variables, including cellulosic polymer type, amount, ionic strength, and viscosity, were evaluated for effects on API dissolution/solubility and crystallization processes.

View Article and Find Full Text PDF

Nanomedicines are often designed to target and treat solid tumors. Unfortunately, tumor and stroma composed of dense extracellular matrix, abnormal vascular barriers, elevated interstitial fluid pressure, et al., which impede the access and accumulation of nanomedicines into tumors.

View Article and Find Full Text PDF

Background: Abnormal expression of stromal cells and extracellular matrix in tumor stroma creates a tight barrier, leading to insufficient extravasation and penetration of therapeutic agents. Cancer-associated fibroblasts (CAFs) take on pivotal roles encouraging tumor progression.

Method: To surmount the refractoriness of stroma, we constructed a multi-targeting combined scenario of anti-CAFs agent tranilast and antitumor agent docetaxel micelles (DTX-Ms).

View Article and Find Full Text PDF

Introduction: Acceleration and improvement of penetration across cell-membrane interfaces of active targeted nanotherapeutics into tumor cells would improve tumor-therapy efficacy by overcoming the issue of poor drug penetration. Cell-penetrating peptides, especially synthetic polyarginine, have shown promise in facilitating cargo delivery. However, it is unknown whether polyarginine can work to overcome the membrane interface in an inserted pattern for cyclic peptide ligand-mediated active targeting drug delivery.

View Article and Find Full Text PDF
Article Synopsis
  • The CD44 protein is a key receptor on tumor cells that binds hyaluronan (HA), but the weak interaction limits effective drug delivery.
  • Researchers enhanced HA's binding to CD44 using a HA tetrasaccharide cluster and modified a polyamidoamine (PAMAM) dendrimer for better siRNA delivery.
  • The resulting nanocomplexes improved siRNA uptake in cells, successfully reducing GFP protein and mRNA levels, which could enhance the use of PAMAM nanomaterials in clinical settings.
View Article and Find Full Text PDF
Article Synopsis
  • * The study introduces an "intelligent peptide-gathering mechanical arm" (Int PMA) to enhance the selectivity of R-liposome-based drug delivery, utilizing specific peptides for tumor targeting and release based on tumor microenvironmental cues.
  • * Experimental results show that the design allows for controlled cargo release in response to tumor-related enzymes, with successful in vitro and in vivo performance, demonstrating promise for targeted cancer therapies.
View Article and Find Full Text PDF

The goal of this work was to compare fenofibrate (FEN)-containing self-micellizing solid dispersion (SmSD) and non-self-micellizing solid dispersion (NsSD) systems. Exploration of underlying mechanisms to improve FEN dissolution/solubility profiles was conducted to understand the enhanced therapeutic potential. SmSD and NsSD of FEN systems (SmSD/FEN and NsSD/FEN) were fabricated using a fuse-quench cooling method.

View Article and Find Full Text PDF

Metastasis of cancer makes up the vast majority of cancer-related deaths, and it usually initiates from tumor cells invasiveness and develops through tumor neovasculature. In this work, we have fabricated a CD44/neuropilin dual receptor-targeting nanoparticulate system (tLyP-1-HT NPs) with endogenous or FDA approved components for treating metastatic triple negative breast cancer (TNBC). The enhanced specific targeting of tLyP-1-HT NPs to both metastatic tumor cells and metastasis-supporting tumor neovasculature was contributed by means of CD44/neuropilin dual receptor-mediated interaction.

View Article and Find Full Text PDF

Glioblastoma multiforme (GBM) is the most common and deadly brain cancer, characterized by its aggressive proliferation to adjacent tissue and high recurrence rate. We studied the efficacy and related mechanisms of the combination of cyclopamine (Cyp, a Sonic-hedgehog pathway (Shh) inhibitor) and temozolomide (TMZ, the clinically most used chemotherapeutic agent) in anti-GBM treatment. The micellarized Cyp (MCyp) showed better performance than Cyp solution in inhibiting GBM cells proliferation (3.

View Article and Find Full Text PDF
Article Synopsis
  • Small interfering RNA (siRNA) is a promising cancer treatment but requires an effective delivery system due to its instability and challenges in cellular uptake.
  • A new activatable cell-penetrating peptide (ACPP) was designed to respond to the acidic environment of tumors, improving siRNA delivery by facilitating its escape from cellular compartments after uptake.
  • Studies showed that these ACPP-modified liposomes enhanced cellular uptake, reduced tumor-related protein expression, and increased cancer cell death, suggesting this system could be a valuable approach for siRNA-based therapies in cancer treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Cell-penetrating peptides (CPPs), known as "Trojan Horse" peptides, are effective for delivering drugs into cells but are too indiscriminate, making targeted delivery to tumors challenging.
  • To overcome this, researchers developed a masked CPP-doxorubicin conjugate that uses a charge-guided masking technique and a protease-triggered mechanism to ensure that the drug is only activated in tumor environments rich in specific proteases (MMP-2/9).
  • Experiments showed that this conjugate can effectively release its drug upon reaching MMP-2/9-rich tumors, leading to enhanced cytotoxicity against cancer cells while minimizing damage to healthy tissue, suggesting this approach is a promising strategy for targeted cancer therapies.
View Article and Find Full Text PDF
Article Synopsis
  • The treatment of aggressive brain glioblastoma is challenged by the blood-brain barrier (BBB) and blood-tumor barrier (BTB), necessitating targeted therapy approaches.
  • A dual-functional liposomal system was created that uses receptor-specific peptides to effectively deliver both BBB-impermeable siRNA and the chemotherapy drug docetaxel directly to glioblastoma cells.
  • This innovative system showed improved therapeutic outcomes, including gene silencing, increased tumor cell death, and minimal side effects while also positively altering the glioblastoma microenvironment.
View Article and Find Full Text PDF

Polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer, or Soluplus, is a relatively new copolymer and a promising carrier of amorphous solid dispersions. Knowledge on the inherent properties of Soluplus (e.g.

View Article and Find Full Text PDF
Article Synopsis
  • LDL (low-density lipoprotein) is used to deliver drugs to tumors because cancer cells require a lot of cholesterol, leading to the development of a synthetic version (sLDL) to encapsulate paclitaxel-alpha linolenic acid (PALA).
  • PALA-sLDL shows improved drug uptake and cytotoxicity in cells that express specific receptors compared to a standard microemulsion formulation (PALA-ME).
  • In animal studies, PALA-sLDL demonstrated higher tumor targeting and inhibition efficiency than both PALA-ME and Taxol®, while also showing lower toxicity, indicating its potential as an effective cancer treatment carrier.
View Article and Find Full Text PDF

Cell-penetrating peptides are composed of positively-charged amino acids that can mediate molecules or nano-carriers across cell membranes. However, most of the known cell-penetrating peptides have no cell- or tissue-specificity, with affinity to almost all types of cells in internalization. The non-specificity of cell-penetrating peptides is a significant obstacle in the application to targeted delivery of imaging probes and therapeutic agents.

View Article and Find Full Text PDF

This study aims to explore the characteristics of crystallization inhibition by cellulose polymers at the supersaturated states of drugs. The study was performed by simulating supersaturated process and preparing supersaturated drug solid, and was carried out by measuring the content of drugs at different time points using dissolution apparatus. The types, amounts, ionic intensity and viscosity of cellulose polymers were examined to assess the crystallization inhibition effect on BCS II class drug indomethacin.

View Article and Find Full Text PDF

Poor site-specific delivery and incapable deep-penetration into tumor are the intrinsic limitations to successful chemotherapy. Here, the tumor-homing penetrating peptide tLyP-1-functionalized nanoparticles (tLPTS/HATS NPs), composed of two modularized amphiphilic conjugates of tLyP-1-PEG-TOS (tLPTS) and TOS-grafted hyaluronic acid (HATS), had been fabricated for tumor-targeted delivery of docetaxel (DTX). The prepared tLPTS/HATS NPs had about 110 nm in mean diameter, high drug encapsulation efficiency (93%), and sustained drug release behavior.

View Article and Find Full Text PDF

Cell-penetrating peptides (CPPs) offer a non-selective and receptor-independent mode to promote cellular uptake. Although the non-specificity of CPP-mediated internalization allows this approach applicable to a wide range of tumor types potentially, their universality is a significant obstacle to their clinical utility for targeted delivery of cancer therapeutics and imaging agents. Accordingly, many reports have focused on selective switching of systemically delivered inert CPPs into their active form in lesions (tumor).

View Article and Find Full Text PDF

Multidrug resistance (MDR) presents a clinical obstacle to cancer chemotherapy. The main purpose of this study was to evaluate the potential of a hyaluronic acid (HA) and α-tocopheryl succinate (α-TOS) based nanoparticle to enhance cancer cell recognition and overcome MDR, and to explore the underlying mechanisms. A multifunctional nanoparticle, HTTP-50 NP, consisted of HA-α-TOS (HT) conjugate and d-α-tocopheryl polyethylene glycol succinate (TPGS) with docetaxel loaded in its hydrophobic core.

View Article and Find Full Text PDF

There are several obstacles in the process of successful treatment of malignant tumors, including toxicity to normal cells, inefficiency of drug permeation and accumulation into the deep tissue of solid tumor, and multidrug resistance (MDR). In this work, we prepared docetaxel (DTX)-loaded hybrid micelles with DSPE-PEG and TPGS (TPGS/DTX-M), where TPGS serves as an effective P-gp inhibitor for overcoming MDR, and active targeting hybrid micelles (FA@TPGS/DTX-M) with targeting ligand of folate on the hybrid micelles surface offering active targeting to folate receptor-overexpressed tumor cells. A systematic comparative evaluation of these micelles on cellular internalization, sub-cellular distribution, antiproliferation, mitochondrial membrane potential, cell apoptosis and cell cycle, permeation and inhibition on 3-dimensional multicellular tumor spheroids, as well as antitumor efficacy and safety assay in vivo were well performed between sensitive KB tumors and resistant KBv tumors, and among P-gp substrate or not.

View Article and Find Full Text PDF

Malignant tumors remain a major health burden throughout the world, and effective therapeutic strategies are urgently needed. Combining gene therapy with chemotherapeutics in a single delivery system is more effective than co-treatment of cancer with individual delivery systems carrying either gene or drug. In this study, a multifunctional folate-decorated and pH-responsive PHD/PPF/siVEGF nanocomplex is developed via a self-assembly process utilizing ternary pre-functionalized polymers with vascular endothelial growth factor targeted siRNA.

View Article and Find Full Text PDF